These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36555393)

  • 1. Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
    Kim S; Choi I; Han IH; Bae H
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effect of Melittin-dKLA Targeting Tumor-Associated Macrophages in Melanoma.
    Han IH; Jeong C; Yang J; Park SH; Hwang DS; Bae H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
    Lee C; Kim S; Jeong C; Cho I; Jo J; Han IH; Bae H
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide.
    Lee C; Jeong H; Bae Y; Shin K; Kang S; Kim H; Oh J; Bae H
    J Immunother Cancer; 2019 Jun; 7(1):147. PubMed ID: 31174610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages.
    Jeong C; Kim J; Han IH; Kim S; Choi I; Kim H; Jeong JH; Bae H
    Front Immunol; 2023; 14():1178776. PubMed ID: 37122692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide.
    Lepland A; Asciutto EK; Malfanti A; Simón-Gracia L; Sidorenko V; Vicent MJ; Teesalu T; Scodeller P
    Mol Pharm; 2020 Jul; 17(7):2518-2531. PubMed ID: 32421341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
    Chen Z; Wu J; Wang L; Zhao H; He J
    Med Oncol; 2022 May; 39(5):83. PubMed ID: 35570226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer.
    Tang C; Jiang ST; Li CX; Jia XF; Yang WL
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis.
    Dai Y; Ji Z; Liang H; Jiang M; Wang L; Bao X; Liu J; Liu M; Yang C
    Cancer Sci; 2024 Jul; 115(7):2235-2253. PubMed ID: 38700108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unconventional p65/p52 NF-κB module regulates key tumor microenvironment-related genes in breast tumor-associated macrophages (TAMs).
    De Paolis V; Troisi V; Bordin A; Pagano F; Caputo V; Parisi C
    Life Sci; 2024 Nov; 357():123059. PubMed ID: 39278618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
    Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages.
    Guo Y; Deng X; Wang S; Yuan Y; Guo Z; Hao H; Jiao Y; Li P; Han S
    Int J Biol Macromol; 2024 Jan; 254(Pt 1):127639. PubMed ID: 37879580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer.
    Zhang R; Shen Y; Zhang Q; Feng X; Liu X; Huo X; Sun J; Hao J
    Cell Death Dis; 2023 Dec; 14(12):850. PubMed ID: 38123542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.
    Cheng N; Bei Y; Song Y; Zhang W; Xu L; Zhang W; Yang N; Bai X; Shu Y; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114298. PubMed ID: 33153969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol prevents lung metastasis of triple-negative breast cancer by regulating polarization and recruitment of macrophages.
    Mei M; Tang L; Zhou H; Xue N; Li M
    Eur J Pharmacol; 2023 Nov; 959():176076. PubMed ID: 37797675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 19. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with
    Bouchard A; Sikner H; Baverel V; Garnier AR; Monterrat M; Moreau M; Limagne E; Garrido C; Kohli E; Collin B; Bellaye PS
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer.
    Padzińska-Pruszyńska I; Kucharzewska P; Matejuk A; Górczak M; Kubiak M; Taciak B; Król M
    Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.